Thompson Street Capital Partner’S Vector Laboratories Acquires Quanta Biodesign
07/25/23, 10:33 AM
Thompson Street Capital Partners (TSCP), a private equity firm based in St. Louis, today announced the acquisition of Quanta BioDesign, the inventor of discrete polyethylene glycol (dPEG®) technology for advanced bioconjugate and payload delivery design for life science and biopharma applications, by Vector Laboratories, a portfolio company of TSCP and the pioneer of innovative proteomic and glycomic research solutions. This acquisition further expands Vector Laboratories’ portfolio of bioconjugation linkers and dyes and builds on its manufacturing and bioconjugation capabilities to better serve partners across biopharma and the life sciences. Terms of the transaction were not disclosed.
Company Info
Company info
Vector Laboratories is a manufacturer of reagents and critical components for the development and production of life sciences tools, diagnostics, and clinical stage biotherapeutics. Absolute Biotech is a global manufacturer and supplier, serving customers with antibody reagents, kits, and services to support annotation, validation, sequencing, engineering, and recombinant antibody manufacturing.